Sonova Holding AG Reports Robust Earnings and Margin Resilience

Sonova Holding AG (ISIN CH0012549785) has maintained its steady growth trajectory, backed by robust earnings and cash generation. The Swiss hearing-care group's recent annual reporting shows solid revenue growth and resilient margins for fiscal year 2023/24.

According to the company's investors section, Sonova reported group sales of around CHF 3.7 billion in fiscal 2023/24, marking an increase from roughly CHF 3.4 billion in the prior fiscal year 2022/23. This revenue progression came as Sonova continued to expand in both hearing instruments and cochlear implants, with organic growth reflecting higher unit volumes as well as price and mix effects in key markets such as Europe and North America.

The company's adjusted EBIT in fiscal 2023/24 was reported in the high hundreds of millions of Swiss francs, with EBIT margin in the mid-teens. Sonova maintained or slightly improved its EBIT margin despite inflationary input-cost pressures and investments in research and development, suggesting that the group has been able to offset cost headwinds through pricing discipline and productivity gains.

Net income growth and cash flow strength also contributed to the company's solid performance. Reported net income attributable to shareholders in fiscal 2023/24 reached several hundred million Swiss francs, up from the prior-year level. Free cash flow generation remained strong, allowing Sonova to fund acquisitions, share buybacks, and dividend payments without overstretching its balance sheet.